XML 98 R87.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting - Reconciliation of Segment Profits to Income Before Taxes (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Segment Reporting Information [Line Items]        
Profits $ 2,665 $ 200 $ 6,097 $ 4,642
Interest income 92 90 257 284
Interest expense (190) (189) (569) (564)
Equity income from affiliates 81 18 93 11
Depreciation and amortization     (3,424) (3,509)
Research and development (2,068) (4,413) (7,538) (8,024)
Restructuring costs (171) (153) (494) (470)
Aggregate charge related to termination of collaboration agreement with Samsung     420 0
Total segment profits        
Segment Reporting Information [Line Items]        
Profits 6,893 6,388 19,476 18,093
Total segment profits | Pharmaceutical segment        
Segment Reporting Information [Line Items]        
Profits 6,479 5,906 18,109 16,657
Total segment profits | Animal Health segment        
Segment Reporting Information [Line Items]        
Profits 409 389 1,273 1,202
Total segment profits | Other segments        
Segment Reporting Information [Line Items]        
Profits 5 93 94 234
Other profits (losses)        
Segment Reporting Information [Line Items]        
Profits 55 (78) (35) 107
Unallocated        
Segment Reporting Information [Line Items]        
Interest income 92 90 257 284
Interest expense (190) (189) (569) (564)
Equity income from affiliates 85 23 101 16
Depreciation and amortization (324) (334) (1,006) (1,036)
Research and development (1,855) (4,208) (6,878) (7,399)
Amortization of purchase accounting adjustments (679) (765) (2,144) (2,322)
Restructuring costs (171) (153) (494) (470)
Aggregate charge related to termination of collaboration agreement with Samsung (420) 0 (420) 0
Other unallocated, net $ (821) $ (574) $ (2,191) $ (2,067)